In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Silk Road Medical nets $128mm in IPO

Executive Summary

Silk Road Medical Inc. (stroke prevention devices used in minimally invasive transcarotid surgeries) netted $128mm in its initial public offering of 6.9mm shares (including the overallotment) at $20, the high end of its anticipated range. Three days prior to the final pricing, the company announced it planned to sell 4.7mm shares between $15-17, and then two days later upped the offering to 6mm shares between $19-20, before pricing at the high end of that range.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies